257
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Changes of urinary phospholipids in the chronic kidney disease patients

, , , , , , , , & show all
Pages 601-606 | Received 05 Jul 2013, Accepted 19 Aug 2013, Published online: 13 Sep 2013

References

  • Boini KM, Zhang C, Xia M, et al. (2010). Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J Pharmacol Exp Ther 334:839–46
  • Brouwers JF. (2011). Liquid chromatographic-mass spectrometric analysis of phospholipids. Chromatography, ionization and quantification. Biochim Biophys Acta 1811:763–75
  • Jacobs RL, Zhao Y, Koonen DP, et al. (2010). Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity. J Biol Chem 285:22403–13
  • Jia LW, Wang C, Zhao SM, et al. (2007). Metabolomic identification of potential phospholipid biomarkers for chronic glomerulonephritis by using high performance liquid chromatography–mass spectrometry. J Chromatogr B 860:134–40
  • Liebisch G, Lieser B, Rathenberg J, et al. (2004). High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim Biophys Acta 1686:108–17
  • Liu S, Che M, Xue S, et al. (2013). Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients. Biomarkers 18:95–101
  • Makinen VP, Tynkkynen TL, Soininen P, et al. (2012). Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study). Metabolomics 8:369–75
  • Muscat JE, Liu A, Richie JP Jr. (2011). A comparison of creatinine vs. specific gravity to correct for urinary dilution of cotinine. Biomarkers 16:206–11
  • Nicholson JK, Lindon JC, Holmes E. (1999). ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–9
  • Noto A, Cibecchini F, Fanos V, Mussap M. (2013). NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury. Biomed Res Int 2013:Article ID 612032, 6 pp
  • Peterson BL, Cummings BS. (2006). A review of chromatographic methods for the assessment of phospholipids in biological samples. Biomed Chromatogr 20:227–43
  • Ralib AM, Pickering JW, Shaw GM, et al. (2012). Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 23:322–33
  • Retra K, Bleijerveld OB, van Gestel RA, et al. (2008). A simple and universal method for the separation and identification of phospholipid molecular species. Rapid Commun Mass Spectrom 22:1853–62
  • Zhao YY, Cheng XL, Wei F, et al. (2012a). Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Biomarkers 17:48–55
  • Zhao YY, Liu J, Cheng XL, et al. (2012b). Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin Chim Acta 413:642–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.